Literature DB >> 32331970

Overnight orthokeratology.

Mark A Bullimore1, Leah A Johnson2.   

Abstract

Overnight orthokeratology lenses are approved in countries all over the world for the temporary reduction in myopia, and recently, one lens design has received regulatory approval for myopia control in Europe. The modern orthokeratology lens has a substantial history from its origins of attempting to flatten the corneal curvature with a spherical rigid contact lens to sophisticated gas permeable lenses, designed to reshape the cornea. These lenses are predominantly prescribed for children to slow myopia progression and limit axial elongation of the eye. This article reviews the peer-reviewed literature on the efficacy of orthokeratology for myopia control, sustainability after treatment is discontinued, and the safety concerns of overnight contact lens wear. Future avenues of research are discussed.
Copyright © 2020 The Author(s). Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Microbial keratitis; Myopia; Myopia control; Overnight orthokeratology; RGP lenses; Safety

Year:  2020        PMID: 32331970     DOI: 10.1016/j.clae.2020.03.018

Source DB:  PubMed          Journal:  Cont Lens Anterior Eye        ISSN: 1367-0484            Impact factor:   3.077


  14 in total

1.  Short and long term corneal biomechanical analysis after overnight orthokeratology.

Authors:  Amelia Nieto-Bona; Paloma Porras-Ángel; Adela Elena Ayllón-Gordillo; Gonzalo Carracedo; David P Piñero
Journal:  Int J Ophthalmol       Date:  2022-07-18       Impact factor: 1.645

2.  Photopic pupil size change in myopic orthokeratology and its influence on axial length elongation.

Authors:  Meng-Jun Zhu; Li Ding; Lin-Lin Du; Jun Chen; Xian-Gui He; Shan-Shan Li; Hai-Dong Zou
Journal:  Int J Ophthalmol       Date:  2022-08-18       Impact factor: 1.645

3.  Night contact lenses used for myopia - personal experience.

Authors:  Camelia Margareta Bogdănici; Irina Andreea Niagu; Alisa Bejan; Ștefan Tudor Bogdănici; Silvia Sălăvăstru
Journal:  Rom J Ophthalmol       Date:  2022 Apr-Jun

Review 4.  The Combined Effect of Low-dose Atropine with Orthokeratology in Pediatric Myopia Control: Review of the Current Treatment Status for Myopia.

Authors:  José-María Sánchez-González; Concepción De-Hita-Cantalejo; María-José Baustita-Llamas; María Carmen Sánchez-González; Raúl Capote-Puente
Journal:  J Clin Med       Date:  2020-07-24       Impact factor: 4.241

5.  Multifocal Orthokeratology versus Conventional Orthokeratology for Myopia Control: A Paired-Eye Study.

Authors:  Martin Loertscher; Simon Backhouse; John R Phillips
Journal:  J Clin Med       Date:  2021-01-24       Impact factor: 4.241

6.  The Effect of Different Cleaning Methods on Protein Deposition and Optical Characteristics of Orthokeratology Lenses.

Authors:  Chen-Ying Su; Lung-Kun Yeh; Yi-Fei Tsao; Wen-Pin Lin; Chiun-Ho Hou; Hsueh-Fang Huang; Chi-Chun Lai; Hsu-Wei Fang
Journal:  Polymers (Basel)       Date:  2021-12-09       Impact factor: 4.329

7.  Changes in subfoveal choroidal thickness in myopic children with 0.01% atropine, orthokeratology, or their combination.

Authors:  Qian Hao; Qi Zhao
Journal:  Int Ophthalmol       Date:  2021-05-05       Impact factor: 2.031

8.  A new approach for quantifying epithelial and stromal thickness changes after orthokeratology contact lens wear.

Authors:  Ziying Ran; Joshua Moore; Fan Jiang; Hongmei Guo; Ashkan Eliasy; Bernardo T Lopes; FangJun Bao; Jun Jiang; Ahmed Abass; Ahmed Elsheikh
Journal:  R Soc Open Sci       Date:  2021-12-22       Impact factor: 2.963

Review 9.  Does Orthokeratology Wearing Affect the Tear Quality of Children?

Authors:  Zhengyang Tao; Jiao Wang; Minjuan Zhu; Zhihong Lin; Jun Zhao; Yu Tang; Hongwei Deng
Journal:  Front Pediatr       Date:  2022-01-18       Impact factor: 3.418

10.  Prevalence and time trends of refractive error in Chinese children: A systematic review and meta-analysis.

Authors:  Yi Tang; Aiming Chen; Minjie Zou; Zhenzhen Liu; Charlotte Aimee Young; Danying Zheng; Guangming Jin
Journal:  J Glob Health       Date:  2021-07-17       Impact factor: 4.413

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.